Côd QR

The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)

Abstract Background The oral gonadotropin-releasing hormone antagonist relugolix, which temporarily stops menstruation, is used to treat heavy menstrual bleeding, pelvic pressure, and low back pain in women with uterine fibroids. Treatment can also help women recover from low hemoglobin levels and p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Mari Kitade, Jun Kumakiri, Hiroyuki Kobori, Keisuke Murakami
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMC 2024-05-01
Cyfres:Trials
Pynciau:
Uterine fibroids
Leiomyomas
Preoperative therapy
Intraoperative blood loss
Laparoscopic myomectomy
GnRH antagonist
Mynediad Ar-lein:https://doi.org/10.1186/s13063-024-08170-1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg